|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts Receivable | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Intellectual property – software | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| Deferred Compensation | ||||||||||||||||||||
| Total Long-Term Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due to related party | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Deferred Compensation Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Common Stock, $0.001 par value 100,000,000 authorized, Common Stock, 25,219,895 and 25,219,895 shares issued and outstanding at March 31 and December 31, 2025, respectively | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Common Stock Class A Member | ||||||||||||||||||||
| Common Stock Class B Member | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Total common Stock, $0.001 par value 100,000,000 authorized, Common Stock, 25,219,895 and 25,219,895 shares issued and outstanding at March 31 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional Paid In Capital | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Total stockholders’ Equity | ||||||||||||||||||||
| Non Controlling Interest | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| TOTAL Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...